This article discusses the development of orally administered mini-tablets containing atomoxetine hydrochloride, aimed at improving medication compliance in children with ADHD.
It highlights the evaluation of these mini-tablets in a rat model to assess their effectiveness and palatability compared to traditional capsule forms.